AAGH America Great Health (PK)

Item 5.02. DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

On October 7th, 2018, the Company announced that Mr. Jiaxin Xue was appointed to the Company's Board of Directors and Executive Vice Chairman, also the Chief Executor of China Branch, and on January 12th, 2018, the Company announced that Mr. Rex Chang was appointed to the Company’s Board of Director and  Executive Vice Chairman.

Mr. Jiaxin Xue is graduate from Henan Medical University, he also obtain Doctor degree in Natural Medicine from American Naturopathic University, Master's degree in Social Medicine and Health Management from Peking Union Medical College, Mr. Xue obtained PhD degree in Social Economics, School of Philosophy and Sociology from Beijing Normal University. He is an experienced specialist involves comprehensive fields such as medical treatment, medicine, health, rehabilitation, and elderly care. It mainly focuses on the interpretation and analysis of national pharmaceutical policies and regulations and medical environment safety, strategic management of pharmaceutical projects and strategic planning and operation, project branding and business diagnosis analysis, and optimization of pharmaceutical market management Operation strategy diagnosis, project performance evaluation and economic market risk analysis, brand marketing system construction and chain operation management, pharmaceutical investment and financing management and operational risk control, etc.

From 2007 to 2008, Mr. Xue was the Deputy Director of the Chinese Red Cross Rescue Training Department, Vice President of the Business Development Department of Haihong Pharmaceutical Holdings; in 2009 Mr. Xue founded Mai Dingsheng International Medical Investment Service Agency. From 2014 to the present, Mr. Xue is the Deputy Dean of the International College of Natural Therapy, Executive Vice President of the Zhongguancun Industry Integration and Transformation Promotion Association and Chairman of the International Medical Care Industry Committee, Deputy Director of the Chronic Disease Prevention Fund Management Committee of the China Medical and Health Development Foundation, Chinese Nationality Deputy Director of the Internet + Medical Work Committee of the Health Association, Deputy Director of the Clinical Medicine Center of the Research Institute of the National Health Commission. No transactions occurred since the beginning of the Company's last fiscal year to which the Company was a party in which Mr. Xue had or is to have a direct or indirect material interest.

Mr. Rex Chang is an experienced GPA Consultant and an international trade specialist. He started in manufacturing facilities, well-trained in commercial and industrial, import-export, QC/QA, marketing development and government procurement agreement fields. Mr. Chang served as Chief Executive Officer in U. S. Asia Chamber of Commerce, and Chief Executive Officer- Asian Marketing in U.S. Foods International, he also served as Chief Executive Officer in New Cathay International Development Corp. Mr. Chang also holds the positions in Center for International Trade Development and Taiwan Trade Center as Consultant. No transactions occurred since the beginning of the Company's last fiscal year to which the Company was a party in which Mr. Chang had or is to have a direct or indirect material interest.